CD274 and renal cell carcinoma: RCC exhibits a significant and intricate infiltration of immune cells and widespread expression of PD-L1 (Deleuze et al., 2020), which has the potential to serve as a reliable biomarker for immunotherapies (Considine and Hurwitz, 2019).